Cargando…
Feasibility and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Carcinomatosis: A Retrospective Cohort Study
Background. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) has been introduced as a novel repeatable treatment for peritoneal carcinomatosis. The available evidence from the pioneer center suggests good tolerance and high response rates, but independent confirmation is needed. A single-cen...
Autores principales: | Hübner, Martin, Teixeira Farinha, Hugo, Grass, Fabian, Wolfer, Anita, Mathevet, Patrice, Hahnloser, Dieter, Demartines, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346367/ https://www.ncbi.nlm.nih.gov/pubmed/28331493 http://dx.doi.org/10.1155/2017/6852749 |
Ejemplares similares
-
Impact of Pressurized Intraperitoneal Aerosol Chemotherapy on Quality of Life and Symptoms in Patients with Peritoneal Carcinomatosis: A Retrospective Cohort Study
por: Teixeira Farinha, Hugo, et al.
Publicado: (2017) -
Inflammatory Response and Toxicity After Pressurized IntraPeritoneal Aerosol Chemotherapy
por: Teixeira Farinha, Hugo, et al.
Publicado: (2018) -
The role of cytology in patients undergoing pressurized intraperitoneal aerosol chemotherapy (PIPAC) treatment for peritoneal carcinomatosis
por: Deban, Mélina, et al.
Publicado: (2023) -
Early postoperative outcomes of staging laparoscopy for peritoneal metastases with or without pressurized intra-peritoneal aerosol chemotherapy (PIPAC)
por: Teixeira Farinha, Hugo, et al.
Publicado: (2022) -
Treatment Response After Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastases of Colorectal Originf
por: Hübner, Martin, et al.
Publicado: (2022)